Caredx, INC 8-K filings

NASDAQ

16 Apr 2024

CDNA

8-K: CareDx Appoints John W. Hanna as New President and CEO, Bolstering Leadership Team

CareDx has appointed John W. Hanna as its new President and Chief Executive Officer, effective April 15, 2024, bringing extensive experience in molecular diagnostics and life sciences.

NASDAQ

11 Mar 2024

CDNA

Caredx, INC

8-K: CareDx Appoints R. Bryan Riggsbee to Board of Directors and Audit Committee Chair

CareDx has appointed R. Bryan Riggsbee to its Board of Directors and as Chairperson of the Audit and Finance Committee, effective March 11, 2024.

NASDAQ

28 Feb 2024

CDNA

Caredx, INC

8-K: CareDx Reports Full Year 2023 Results, Exceeds Revenue Guidance Despite Medicare Challenges

CareDx exceeded its full-year 2023 revenue guidance, reaching $280.3 million, despite a challenging year impacted by Medicare coverage changes.